237 related articles for article (PubMed ID: 12744467)
21. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.
Yeo EJ; Chun YS; Cho YS; Kim J; Lee JC; Kim MS; Park JW
J Natl Cancer Inst; 2003 Apr; 95(7):516-25. PubMed ID: 12671019
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of angiogenesis in human pancreatic cancer.
Ikeda N; Adachi M; Taki T; Huang C; Hashida H; Takabayashi A; Sho M; Nakajima Y; Kanehiro H; Hisanaga M; Nakano H; Miyake M
Br J Cancer; 1999 Mar; 79(9-10):1553-63. PubMed ID: 10188906
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas.
Vaquero J; Zurita M; Coca S; Oya S; Morales C
Surg Neurol; 2000 Sep; 54(3):229-34; discussion 234. PubMed ID: 11118569
[TBL] [Abstract][Full Text] [Related]
24. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
25. [Immunohistochemical study on central nervous system cavernous hemangiomas].
Zhao Y; Mao Y; Zhou LF; Zhang YL
Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(7):544-7. PubMed ID: 12887740
[TBL] [Abstract][Full Text] [Related]
26. Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.
Tabouret E; Tchoghandjian A; Denicolai E; Delfino C; Metellus P; Graillon T; Boucard C; Nanni I; Padovani L; Ouafik L; Figarella-Branger D; Chinot O
Oncotarget; 2015 May; 6(13):11664-75. PubMed ID: 25860928
[TBL] [Abstract][Full Text] [Related]
27. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
28. Expression of Ki-67 antigen and vascular endothelial growth factor in sporadic and neurofibromatosis type 2-associated schwannomas.
Saito K; Kato M; Susaki N; Nagatani T; Nagasaka T; Yoshida J
Clin Neuropathol; 2003; 22(1):30-4. PubMed ID: 12617191
[TBL] [Abstract][Full Text] [Related]
29. Neoplastic cells are a rare component in human glioblastoma microvasculature.
Rodriguez FJ; Orr BA; Ligon KL; Eberhart CG
Oncotarget; 2012 Jan; 3(1):98-106. PubMed ID: 22298889
[TBL] [Abstract][Full Text] [Related]
30. Graphic analysis of microscopic tumor cell infiltration, proliferative potential, and vascular endothelial growth factor expression in an autopsy brain with glioblastoma.
Nagashima G; Suzuki R; Hokaku H; Takahashi M; Miyo T; Asai J; Nakagawa N; Fujimoto T
Surg Neurol; 1999 Mar; 51(3):292-9. PubMed ID: 10086494
[TBL] [Abstract][Full Text] [Related]
31. Expression of hypoxia-related tissue factors correlates with diminished survival of adjuvantly treated patients with chromosome 1p aberrant oligodendroglial neoplasms and therapeutic implications.
Birner P; Preusser M; Gelpi E; Berger J; Gatterbauer B; Ambros IM; Ambros PF; Acker T; Plate KH; Harris AL; Hainfellner JA
Clin Cancer Res; 2004 Oct; 10(19):6567-71. PubMed ID: 15475445
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole.
Oliver VK; Patton AM; Desai S; Lorang D; Libutti SK; Kohn EC
J Cell Physiol; 2003 Oct; 197(1):139-48. PubMed ID: 12942550
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.
Sipos B; Weber D; Ungefroren H; Kalthoff H; Zühlsdorff A; Luther C; Török V; Klöppel G
Int J Cancer; 2002 Dec; 102(6):592-600. PubMed ID: 12448000
[TBL] [Abstract][Full Text] [Related]
34. Proliferation of vascular smooth muscle cells in glioblastoma multiforme.
Takeuchi H; Hashimoto N; Kitai R; Kubota T; Kikuta K
J Neurosurg; 2010 Aug; 113(2):218-24. PubMed ID: 19929197
[TBL] [Abstract][Full Text] [Related]
35. Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption.
Rubenstein JL; Kim J; Ozawa T; Zhang M; Westphal M; Deen DF; Shuman MA
Neoplasia; 2000; 2(4):306-14. PubMed ID: 11005565
[TBL] [Abstract][Full Text] [Related]
36. Loss of chromosome 10 in glioblastoma: relation to proliferation and angiogenesis.
Horiguchi H; Hirose T; Sano T; Nagahiro S
Pathol Int; 1999 Aug; 49(8):681-6. PubMed ID: 10504534
[TBL] [Abstract][Full Text] [Related]
37. Angiogenesis in human normal and pathologic adrenal cortex.
Bernini GP; Moretti A; Bonadio AG; Menicagli M; Viacava P; Naccarato AG; Iacconi P; Miccoli P; Salvetti A
J Clin Endocrinol Metab; 2002 Nov; 87(11):4961-5. PubMed ID: 12414859
[TBL] [Abstract][Full Text] [Related]
38. The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study.
Zhang JF; Chen Y; Qiu XX; Tang WL; Zhang JD; Huang JH; Lin GS; Wang XF; Lin ZX
Tumour Biol; 2016 Mar; 37(3):3797-805. PubMed ID: 26472724
[TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
Shweiki D; Itin A; Soffer D; Keshet E
Nature; 1992 Oct; 359(6398):843-5. PubMed ID: 1279431
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of vascular endothelial growth factor isoforms drives oxygenation and growth but not progression to glioblastoma multiforme in a human model of gliomagenesis.
Sonoda Y; Kanamori M; Deen DF; Cheng SY; Berger MS; Pieper RO
Cancer Res; 2003 Apr; 63(8):1962-8. PubMed ID: 12702589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
